ClinicalTrials.gov
ClinicalTrials.gov Menu

Time to Perform Lung Function Test in Cystic Fibrosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01737801
Recruitment Status : Completed
First Posted : November 30, 2012
Last Update Posted : November 30, 2012
Sponsor:
Information provided by (Responsible Party):
Cecilia Rodriguez, Karolinska University Hospital

Brief Summary:

Time to perform lung function test after chest physiotherapy in cystic fibrosis.

The investigators study FEV1(forced expiratory volume in one second) and FVC (forced vital capacity).


Condition or disease Intervention/treatment Phase
Cystic Fibrosis Procedure: Lung function test Not Applicable

Detailed Description:
The patients perform spirometry before, direct after, 30 minutes, 1 hour, 2 hours, and 3 hours after physiotherapist. The investigators want to study the FEV1 and FVC.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 24 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Time to Perform Lung Function Test in Cystic Fibrosis After Chest Physiotherapy.
Study Start Date : February 2008
Actual Primary Completion Date : January 2012
Actual Study Completion Date : September 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Cystic Fibrosis
U.S. FDA Resources

Arm Intervention/treatment
Experimental: Lung function test
Lung function test
Procedure: Lung function test
Lung function test.
Other Name: Lung function test.



Primary Outcome Measures :
  1. Lung function test. FEV1 and FVC [ Time Frame: 2 days ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   5 Years to 80 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with cystic fibrosis

Exclusion Criteria:

  • patients with cystic fibrosis who could not stay at the clinic for more than 4 hrs.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01737801


Locations
Sweden
Karolinska University Hospital
Stockholm, Sweden
Sponsors and Collaborators
Karolinska University Hospital
Investigators
Principal Investigator: Cecilia Rodriguez, Physio Karolinska Institutet

Responsible Party: Cecilia Rodriguez, Physiotherapist, Karolinska University Hospital
ClinicalTrials.gov Identifier: NCT01737801     History of Changes
Other Study ID Numbers: 2012-CF-2
First Posted: November 30, 2012    Key Record Dates
Last Update Posted: November 30, 2012
Last Verified: November 2012

Keywords provided by Cecilia Rodriguez, Karolinska University Hospital:
Lung function
Physiotherapy

Additional relevant MeSH terms:
Fibrosis
Cystic Fibrosis
Pathologic Processes
Pancreatic Diseases
Digestive System Diseases
Lung Diseases
Respiratory Tract Diseases
Genetic Diseases, Inborn
Infant, Newborn, Diseases